Core outcome set for preventive intervention trials in chronic and episodic migraine (COSMIG): an international, consensus-derived and multistakeholder initiative

• Kirstie Haywood,
• Martin Underwood,
• Stavros Petrou,
• Gemma Pearce,
• Rachel Potter,
• Shilpa Patel,
• Kimberley Stewart,
• Manjit Matharu,
• Robert Froud,
• Brendan Davies,
• Vivien Nichols,
• Richard Lipton,
• Barbara Box,
• Lynne Muldoon,
• Regina Rendas-Baum,
• Anne-Marie Logan,
• Rigor Jensen

Affiliations

Kirstie Haywood

Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK

Martin Underwood

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK

Stavros Petrou

Nuffield Department of Primary Care Health Sciences, Oxford, UK

Gemma Pearce

Department of Psychology and Behavioural Sciences, Coventry University, Coventry, UK

Rachel Potter

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK

Shilpa Patel

Kimberley Stewart

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK

Manjit Matharu

The Headache Group, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK

Robert Froud

Institute of Health Sciences, Kristiania University College, Oslo, Norway

Brendan Davies

Vivien Nichols

Richard Lipton

Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA

Barbara Box

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK

Lynne Muldoon

Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK

Regina Rendas-Baum

QualityMetric Incorporated, Lincoln, Rhode Island, USA

Anne-Marie Logan

Neurology Department, St George`s University Hospitals NHS Foundation Trust, London, UK

Rigor Jensen